RENBP and atherosclerosis: Some of these include cancer pathways, lipid‐metabolism related pathways such as lipid and atherosclerosis, tuberculosis disease, hepatitis B disease, TNF signaling pathway, prostate cancer disease, toxoplasmosis disease, fluid shear stress and atherosclerosis, AGE‐RAGE signaling pathway in diabetic complications, and human T‐cell leukemia virus 1 infection disease (Figure 4).